Ï㽶ÊÓƵ

David K. Gaffney
( out of 81 reviews )

David K. Gaffney, MD, PhD, FACR, FABS, FASTRO

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
Salt Lake City
801-581-2396

Sugar House Health Center

Salt Lake City
801-581-2000

  • Senior Director for Clinical Research, Huntsman Cancer Institute

    Professor, Department of Radiation Oncology, Ï㽶ÊÓƵ of Utah

    J Robert and Ann K Stewart Endowed Professorship

    David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

    Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

    In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

    Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the Ï㽶ÊÓƵ of Utah School of Medicine.

    Specialties

    Board Certification

    American Board of Radiology (Radiation Oncology)

    Patient Rating

    4.9 /5
    ( out of 81 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    July 25, 2024
    HUNTSMAN CANCER CENTER

    I trust Dr Gaffney explicitly and feel completely comfortable with his care and concern for my situation and how to move forward with the best way to treat my health issues.

    July 14, 2024
    HUNTSMAN CANCER CENTER

    Dr. Gaffney is very caring and wonderful doctor. I feel so confident and comfortable to have him as my radiation oncologist.

    July 13, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Gaffney is very relatable.

    June 21, 2024
    HUNTSMAN CANCER CENTER

    Dr.Gaffney is a caring, confident, and considerate doctor. He knows what he¿s doing, and leaves his patients assured that they are receiving the very best of care. He works hard, and follows up with care. I can rest knowing I¿m going to receive the upmost care from him.

    June 07, 2024
    HUNTSMAN CANCER CENTER

    Dr Gaffney is very kind and understanding. He listens to me, and makes sure I understand what the treatment will be and what I need to do to make it successful. I trust his judgement, and feel like he knows what he¿s doing, and wants to do the very best he can. I feel like he cares about me as a person, and wants me to have the very best outcome. He¿s a very considerate doctor who puts his whole self in treating his patients. I feel really good about being in his care.

    May 27, 2024
    SUGAR HOUSE HEALTH CENTER

    Muy amable y profesional

    May 27, 2024
    HUNTSMAN CANCER CENTER

    we only met for about 5 minutes ? The nurse in attendance "Judith" is the real deal.

    May 19, 2024
    HUNTSMAN CANCER CENTER

    Thank you to you, to your nursing staff, front facing desk staff and doctor trainee - all of you exhibited care and heart lightening compassion while asking questions, taking down new history, and delivering specific medical care needs for my cancer treatment. Grateful for the generosity of everyone's care.

    May 14, 2024
    HUNTSMAN CANCER CENTER

    Dr. Gaffney is an excellent doctor. I trusted his opinions and was grateful for his knowledge and professionalism. Thanks again to him and all his team.

    See More Patient Comments

  • Senior Director for Clinical Research, Huntsman Cancer Institute

    Professor, Department of Radiation Oncology, Ï㽶ÊÓƵ of Utah

    J Robert and Ann K Stewart Endowed Professorship

    David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology, Senior Director for Clinical Research, and J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. His main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

    Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

    In addition, Dr. Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

    Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the Ï㽶ÊÓƵ of Utah School of Medicine.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary
    Board Certification
    American Board of Radiology (Radiation Oncology)

    Education history

    Residency Radiation Oncology - Ï㽶ÊÓƵ of Utah Resident
    LDS Hospital Intern
    Doctoral Training Biochemistry - Medical College of Wisconsin Ph.D.
    Medicine - Medical College of Wisconsin M.D.
    Undergraduate Chemistry - Ï㽶ÊÓƵ of Colorado B.A.

    Selected Publications

    Journal Article

    1. Gaffney D, Suneja G, Weil C, Creutzberg C (2024). FIGO Endometrial 2023 is better for radiation oncology patients. Pract Radiat Oncol. ()
    2. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. Eur J Cancer, 201, 113913. ()
    3. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R II, Glaser S, Holmes J, Howitt BE, Kendra K, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian N, Espinosa S (2024). Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(2), 117-135. ()
    4. Roach E, Hutten R, Johnson S, Suneja G, Tward J, Petereit D, Gaffney D (2024). The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy. Brachytherapy, 23(3), 360-367. ()
    5. Harari CM, Brower JV, Gaffney DK, Bradley KA (2024). Navigating the Complexities of Lymph Node Management in Vulvar Cancer: Insights and Perspectives. Pract Radiat Oncol. ()
    6. Zhao H, Sarkar V, St James S, Paxton A, Su FF, Price RG, Dial C, Poppe M, Gaffney D, Salter B (2024). Verification of surface-guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT-on-rails and kV-2D alignment. J Appl Clin Med Phys, 25(2), e14263. ()
    7. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S (2023). NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw, 21(12), 1224-1233. ()
    8. Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu B (2023). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clin Lymphoma Myeloma Leuk, 24(2), 94-104.e6. ()
    9. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney DK (2023). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34. ()
    10. Hutten RJ, Weil CR, King AJ, Barney B, Bylund CL, Fagerlin A, Gaffney DK, Gill D, Scherer L, Suneja G, Tward JD, Warner EL, Werner TL, Whipple G, Evans J, Johnson SB (2023). Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO Oncol Pract, 19(11), OP2300179. ()
    11. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee FIGO Womens Cancer Committee (2023). FIGO staging of endometrial cancer: 2023. J Gynecol Oncol, 34(5), e85. ()
    12. Lee SS, Weil CR, Boyd LR, DeCesaris C, Gaffney D, Suneja G (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. Int J Gynecol Cancer, 33(9), 1408-1418. ()
    13. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee FIGO Womens Cancer Committee (2023). FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. ()
    14. Mileshkin LR, Moore KN, Barnes EH, Gebski V, Narayan K, King MT, Bradshaw N, Lee YC, Diamante K, Fyles AW, Small W Jr, Gaffney DK, Khaw P, Brooks S, Thompson JS, Huh WK, Mathews CA, Buck M, Suder A, Lad TE, Barani IJ, Holschneider CH, Van Dyk S, Quinn M, Rischin D, Monk BJ, Stockler MR (2023). Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. Lancet Oncol, 24(5), 468-482. ()
    15. Dwyer K, Bentley IS, Fitzpatrick DA, Saleh AA, Tighe E, McGleenan E, Gaffney D, Walsh G (2023). Recombinant production, characterization and industrial application testing of a novel acidic exo/endo-chitinase from Rasamsonia emersonii. Extremophiles, 27(2), 10. ()
    16. Kunz JN, Huang YJ, Casper AC, Suneja G, Burt LM, Jhingran A, Joyner MM, Harkenrider MM, Small W Jr, Grant JD, Kidd EA, Boucher K, Gaffney DK (2023). Dosimetric Evaluation of OARs from SAVE Protocol. Int J Radiat Oncol Biol Phys. ()
    17. Kunzman J, Hutten R, Kelley K, Harris K, Gaffney DK, DeCesaris C, Suneja G, Burt LM (2023). Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study. European Journal of Gynecological Oncology, 44(2), 25-31.
    18. Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S (2023). Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 21(2), 181-209. ()
    19. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer Med, 12(3), 2624-2636. ()
    20. Chang CP, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Stanford JB, Gaffney D, Mooney K, Hashibe M (2022). Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Support Care Cancer, 31(1), 51. ()
    21. Sherertz T, Jhingran A, Biagioli M, Gaffney D, Elshaikh M, Coleman RL, Harkenrider M, Kidd EA, Jolly S, Yashar C, Portelance L, Wahl A, Venkatesan A, Li L, Small W Jr, American Radium Society (2022). Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. Int J Gynecol Cancer. ()
    22. Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao R (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leuk Lymphoma, 64(2), 1-8. ()
    23. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe M (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572. ()
    24. Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja G (2022). Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy. JCO Oncol Pract, 18(10), e1694-e1703. ()
    25. Weil CR, Parsons MJ, Hutten RJ, Lew FH, Johnson SB, Gaffney DK, Tao R (2022). Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy. Leuk Lymphoma, 63(12), 1-11. ()
    26. Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney DK (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Adv Radiat Oncol, 7(6), 101035. ()
    27. Hu S, Baraghoshi D, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Peoples AR, Gaffney D, Hashibe M (2022). Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med. ()
    28. Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney DK (2022). Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leuk Lymphoma, 63(10), 1-8. ()
    29. Dood R, Trabert B, Werner TL, Gaffney D, Jarboe E (2022). The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers. Int J Gynecol Cancer, 32(8), 1087-1088. ()
    30. Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja G (2022). Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy. Adv Radiat Oncol, 7(3), 100887. ()
    31. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer Med. ()
    32. Hutten RJFenlon JBKessel ACStraessler KMHuang YJGaffney DKSuneja GZempolich KBurt LM (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, epub ahead of print. ()
    33. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. ()
    34. Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD (2021). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw, 19(8), 888-895. ()
    35. Hu Q, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Gren LH, Porucznik C, Stanford JB, Gaffney D, Henry NL, Lopez I, Hashibe M (2021). Disparities in Cardiovascular Disease Risk among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI Cancer Spectr, 5(2). ()
    36. Holcombe RF, Verschraegen CF, Chapman AE, Gaffney D, Goldberg RM, Mesa RA, Milhem M, Mims M, Mitchell EP, Mulkerin D, Vijayakumar S (2021). Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care. J Natl Compr Canc Netw, 19(2), 122-125. ()
    37. Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK (2020). NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys, 109(2), 413-424. ()
    38. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol, 7, 173-182. ()
    39. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao R (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med, 9(21), 7954-7963. ()
    40. Small W Jr, Peltecu G, Puiu A, Corha A, Cocr E, Cigran RG, Plante M, Jhingran A, Stang K, Gaffney D, Bacon M, McCormack M (2020). Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference. Int J Gynecol Cancer, 31, 1061-1067. ()
    41. Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W Jr (2020). Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecol Oncol, 158(2), 460-466. ()
    42. Elledge CR, Beriwal S, Chargari C, Chopra S, Erickson BA, Gaffney DK, Jhingran A, Klopp AH, Small W Jr, Yashar CM, Viswanathan AN (2020). Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations. Gynecol Oncol, 158(2), 244-253. ()
    43. Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. ()
    44. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter AD (2020). NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw, 18(6), 660-666. ()
    45. Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Bruner DW, Kachnic LA (2020). Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. J Clin Oncol, 38(15), 1685-1692. ()
    46. Chang CP, Chen Y, Blackburn B, Abdelaziz S, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Stanford JB, Porucznik CA, Ose J, Fraser A, Smith K, Doherty J, Gaffney D, Hashibe M (2020). Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecol Oncol, 157(2), 529-535. ()
    47. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. ()
    48. McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. ()
    49. Ager BJ, Torgeson A, Francis SR, Burt LM, Gaffney DK, Cannon DM (2019). Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation. Am J Clin Oncol, 43(1), 35-42. ()
    50. Kim S, Park J, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Deshmukh VG, Newman M, Herget K, Porucznik CA, Ose D, Playdon M, Gaffney D, Hashibe M (2019). Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Gynecol Oncol, 156(1), 185-193. ()
    51. Sturdza A, Viswanathan AN, Erickson B, Yashar C, Bruggeman A, Feddock J, Klopp A, Beriwal S, Gaffney D, Han K, Kamrava M (2020). American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers. Brachytherapy, 19(2), 127-138. ()
    52. Zhao H, Williams N, Poppe M, Sarkar V, Wang B, Rassiah-Szegedi P, Huang YJ, Kokeny K, Gaffney D, Salter B (2019). Comparison of surface guidance and target matching for image-guided accelerated partial breast irradiation (APBI). Med Phys, 46(11), 4717-4724. ()
    53. Boothe D, Orton A, Kim J, Poppe MM, Werner TL, Gaffney DK (2019). Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer? Am J Clin Oncol, 42(11), 813-817. ()
    54. Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J (2019). Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(11), 1374-1391. ()
    55. Blackburn BE, Soisson S, Rowe K, Snyder J, Fraser A, Deshmukh V, Newman M, Smith K, Herget K, Kirchhoff AC, Kepka D, Werner TL, Gaffney D, Mooney K, Hashibe M (2019). Prognostic factors for rural endometrial cancer patients in a population-based cohort. BMC Public Health, 19(1), 921. ()
    56. Francis SR, Ager BJ, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK (2019). Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy. Gynecol Oncol, 154(1), 38-44. ()
    57. Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW (2019). Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol, 154(1), 183-188. ()
    58. Boothe D, Wolfson A, Christensen M, Francis S, Werner TL, Gaffney DK (2019). Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use. Am J Clin Oncol, 42(7), 549-554. ()
    59. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2019). Too many women are dying from cervix cancer: Problems and solutions. Obstet Gynecol Surv, 74(3), 154-156. ()
    60. Berek JS, Matsuo K, Grubbs BH, Gaffney DK, Lee SI, Kilcoyne A, Cheon GJ, Yoo CW, Li L, Shao Y, Chen T, Kim M, Mikami M (2019). Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri. J Gynecol Oncol, 30(2), e40. ()
    61. Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, Werner TL, Sause WT, Grant JD, Gaffney DK (2019). Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer? Brachytherapy, 18(4), 453-461. ()
    62. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2019). Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(1), 64-84. ()
    63. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Al-Sarray A, Werner TL, Setiawan VW, Hashibe M (2018). Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. J Natl Cancer Inst, 110(12), 1342-1351. ()
    64. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. ()
    65. Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman JM (2018). Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy. J Gastrointest Oncol, 9(6), 1044-1053. ()
    66. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2018). Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol, 36(24), 2538-2544. ()
    67. Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK (2018). Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. Am J Clin Oncol, 41(8), 784-791. ()
    68. Harkenrider MM, Martin B, Nieto K, Small C, Aref I, Bergman D, Chundury A, Elshaikh MA, Gaffney D, Jhingran A, Lee L, Paydar I, Ra K, Schwarz J, Thorpe C, Viswanathan AN, Small W Jr (2018). Multi-institutional Analysis of Vaginal Brachytherapy Alone for Women With Stage II Endometrial Carcinoma. Int J Radiat Oncol Biol Phys, 101(5), 1069-1077. ()
    69. Olpin J, Chuang L, Berek J, Gaffney D (2018). Imaging and cancer of the cervix in low- and middle-income countries. Gynecol Oncol Rep, 25, 115-121. ()
    70. Ager BJ, Gallardo-Rincn D, de Len DC, Chvez-Blanco A, Chuang L, Dueas-Gonzlez A, Gmez-Garca E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Prez-Plasencia C, Plante M, Poveda A, Gaffney DK (2018). Advancing clinical research globally: Cervical cancer research network from Mexico. Gynecol Oncol Rep, 25, 90-93. ()
    71. Park J, Blackburn BE, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Burt L, Werner T, Gaffney DK, Lopez AM, Mooney K, Hashibe M (2018). Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol, 28(6), 377-384. ()
    72. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Werner TL, Setiawan VW, Hashibe M (2018). Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol, 148(3), 499-506. ()
    73. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2018). Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 16(2), 170-199. ()
    74. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe MM (2017). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. Breast J, 24(1), 7-11. ()
    75. Huang YJ, Su FF, Gaffney DK, Kokeny KE, Zhao H, Rassiah-Szegedi P, Salter BJ, Poppe MM (2018). Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy, 17(6), 956-965. ()
    76. Odei B, Boothe D, Frandsen J, Poppe MM, Gaffney DK (2017). The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk, 17(12), 819-824. ()
    77. Bookman MA, Okamoto A, Stuart G, Yanaihara N, Aoki D, Bacon M, Fujiwara K, Gonzlez-Martn A, Harter P, Kim JW, Ledermann J, Pujade-Lauraine E, Quinn M, Ochiai K, Zeimet A, Marth C, du Bois A, Hilpert F, Pfisterer J, Reuss A, Friedlander M, Wilson MK, Kridelka F, Vergote I, Berek J, Dorigo O, Karam A, Bekkers RLM, Westermann A, Gatsonis C, Ng C, Herrez AC, Ottevanger N, Poveda A, Redondo A, Coleman R, Lu K, Gallardo-Rincn D, Gomez-Garcia E, Joly F, Leary A, Ray-Coquard I, Burger R, Moore KN, Fujiwara H, Hasegawa K, Gleeson N, Levy T, Rosengarten O, Katsumata N, Silverberg SG, Sugiyama T, Chang SJ, Kim BG, Nam BH, Colombo N, Ferrero A, Lorusso D, Scambia G, Edmondson R, McNeish I, Kohn E, Hirte H, McGee J, Provencher D, Sehouli J, Wimberger P, Maenpaa J, Mirza MR, Oza A, Welch S, Gaffney D, Small W, Glasspool R, Gourley C, Millan D, Zang R, Zhu J (2017). Harmonising clinical trials within the Gynecologic Cancer InterGroup: Consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference. Ann Oncol, 28, viii30-viii35. ()
    78. Torgeson A, Boothe D, Poppe MM, Suneja G, Gaffney DK (2017). Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecol Oncol, 147(2), 320-328.
    79. Orio PF, Yashar C, Petereit D, Mourtada F, Klopp A, Gaffney D, Frank S (2017). 2017 American Brachytherapy Society's Annual Meeting Report. Transl Androl Urol, 6(5), 1005-1013. ()
    80. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast, 35, 122-129. ()
    81. Frandsen J, Cannon G, Kokeny KE, Gaffney DK, Wright M, Pena K, Poppe MM (2017). Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review. Breast J, 23(4), 452-455.
    82. Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN, Gaffney DK (2017). Cervical cancer: A global health crisis. Cancer, 123(13), 2404-2412. ()
    83. Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty BG (2017). Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. J Clin Oncol, 35(18), 2037-2043. ()
    84. Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, Erickson B, Fyles A, Goulart J, Harkenrider M, Jhingran A, Klopp A, Koh WJ, Lim K, Petersen I, Portelance L, Small W Jr, Stewart A, Wiebe E, Wolfson A, Yashar C, Bosch W (2016). Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. Int J Radiat Oncol Biol Phys, 95(4), 1191-200. ()
    85. Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D (2016). Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol, 141(3), 501-506. ()
    86. Sharma DN, Gaffney DK (2016). Concurrent chemobrachytherapy in locally advanced cervical carcinoma: A hypothesis worth exploring. Brachytherapy, 15(2), 200-4. ()
    87. Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe MM (2016). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Med Dosim, 41(3), 195-8. ()
    88. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe MM (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Int J Radiat Oncol Biol Phys, 93(5), 1096-103. ()
    89. Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, Small W Jr (2015). ACR Appropriateness Criteria(R) Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park), 29(11), 867-72, 874-5. ()
    90. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL, National Comprehensive Cancer Network (2015). Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 13(11), 1321-31. ()
    91. Lim K, Erickson B, Jrgenliemk-Schulz IM, Gaffney D, Creutzberg CL, Viswanathan A, Portelance L, Beriwal S, Wolfson A, Bosch W, De Los Santos J, Yashar C, Jhingran A, Varia M, El Naqa I, King B, Fyles A (2015). Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol, 5(6), e557-65. ()
    92. Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd S (2015). Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol, 6(5), 516-23. ()
    93. Ly D, Soisson PA, Dodson MK, Sause WT, Gaffney DK (2015). Adjuvant radiation therapy is associated with improved pelvic control and overall survival in FIGO IB endometrial carcinoma with high grade histology. Gynecol Oncol, 138(3), 526-31. ()
    94. Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W Jr, Thomadsen B, Yashar C, Viswanathan A (2015). Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy, 14(5), 587-99. ()
    95. Gaffney DK, Suneja G, Ryu SY, McCormick M, Plante M, Mileshkin L, Small W Jr, Bacon M, Stuart G, Kitchener H (2015). The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. Int J Radiat Oncol Biol Phys, 92(3), 506-8. ()
    96. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W Jr, Gaffney DK (2015). NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer, 121(13), 2156-63. ()
    97. Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, Dodson MK, Werner T, Gaffney DK (2015). Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer. Am J Clin Oncol, 38(3), 283-8. ()
    98. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR 3rd, Mutch D, Fader AN, Remmenga SW, Reynolds RK, Teng N, Tillmanns T, Valea FA, Yashar CM, McMillian NR, Scavone JL (2015). Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw, 13(4), 395-404; quiz 404. ()
    99. Williams NL, Werner TL, Jarboe EA, Gaffney DK (2015). Adenocarcinoma of the cervix: should we treat it differently? Curr Oncol Rep, 17(4), 17. ()
    100. Nickman NA, Ye X, Gaffney DK, Barney RB, Biskupiak JE, Okano GJ, Lee VC, Arellano J (2015). Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer. 13(3), 95-103. ()
    101. Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney DK (2015). Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. Gynecol Oncol, 136(3), 521-8. ()
    102. Suneja G, Bacon M, Small W Jr, Ryu SY, Kitchener HC, Gaffney DK (2015). The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries. Front Oncol, 5, 14. ()
    103. Bagshaw HP, Pappas LM, Kepka DL, Tward JD, Gaffney DK (2014). Patterns of care with brachytherapy for cervical cancer. Int J Gynecol Cancer, 24(9), 1659-64. ()
    104. Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, DSouza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W (2014). Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, 90(2), 320-8. ()
    105. Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W Jr, Varia MA, Wahl AO, Yuh W, Gaffney DK (2014). ACR appropriateness Criteria(R) advanced stage endometrial cancer. Am J Clin Oncol, 37(4), 391-6. ()
    106. Gaffney DK, Jhingran A, Portelance L, Viswanathan A, Schefter T, Weidhaas J, Small W Jr (2014). Radiation therapy oncology group gynecologic oncology working group: comprehensive results. Int J Gynecol Cancer, 24(5), 956-62. ()
    107. Ly D, Rowley BD, Dodson MK, Soisson PA, Jolles CJ, Gaffney DK, Sause WT (2014). Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival. Gynecol Oncol, 133(2), 250-5. ()
    108. Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas J (2014). The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One, 9(4), e94167. ()
    109. Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2014). Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol, 37(2), 131-4. ()
    110. Frandsen JE, Sause WT, Dodson MK, Soisson AP, Belnap TW, Gaffney DK (2014). Survival analysis of endometrial cancer patients with cervical stromal involvement. J Gynecol Oncol, 25(2), 105-10. ()
    111. Lalwani N, Dubinsky T, Javitt MC, Gaffney DK, Glanc P, Elshaikh MA, Kim YB, Lee LJ, Pannu HK, Royal HD, Shipp TD, Siegel CL, Simpson L, Wahl AO, Wolfson AH, Zelop CM, American College of Radiology (2014). ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer. Ultrasound Q, 30(1), 21-8. ()
    112. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR 3rd, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W Jr, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes M (2014). Uterine neoplasms, version 1.2014. J Natl Compr Canc Netw, 12(2), 248-80. ()
    113. Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D (2014). RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Int J Radiat Oncol Biol Phys, 88(1), 101-5.
    114. Cho S, Sun Y, Jarboe EA, Soisson AP, Dodson MK, Gaffney DK, Peterson CM, Jant-Amsbury MM (2013). Mucoadhesive hybrid gel improves intraperitoneal platinum delivery. Int J Pharm, 458(1), 148-55. ()
    115. Wagner AE, Wada D, Bowen G, Gaffney DK (2013). Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. . Br J Dermatol, 169(3), 715-8.
    116. Anker CJ, ODonnell K, Boucher KM, Gaffney DK (2013). Effect of brachytherapy technique and patient characteristics on cervical cancer implant dosimetry. . Med Dosim, 38(4), 430-5.
    117. Gay HA, Barthold HJ, OMeara E, Bosch WR, El Naqa I, Al-Lozi R, Rosenthal SA, Lawton C, Lee WR, Sandler H, Zietman A, Myerson R, Dawson LA, Willett C, Kachnic LA, Jhingran A, Portelance L, Ryu J, Small W Jr, Gaffney D, Viswanathan AN, Michalski JM (2012). Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys, 83(3), e353-62.
    118. Cooke EW, Pappas L, Gaffney DK (2011). Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer, 117(18), 4231-7. ()
    119. Lim K, Small W Jr, Portelance L, Creutzberg C, Jrgenliemk-Schulz IM, Mundt A, Mell LK, Mayr N, Viswanathan A, Jhingran A, Erickson B, De los Santos J, Gaffney D, Yashar C, Beriwal S, Wolfson A, Taylor A, Bosch W, El Naqa I, Fyles A (2011). Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys, 79(2), 348-55.
    120. Ghia AJ, Neeley ES, Gaffney DK (2010). Postoperative radiotherapy use and patterns of care analysis for node positive or parametria positive cervical cancer. Gynecol Oncol, 119(3), 411-6. ()
    121. Weidhaas JB, Li SX, Winter K, Ryu J, Jhingran A, Miller B, Dicker AP, Gaffney D (2009). Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128. Clin Cancer Res, 15(12), 4199-206. ()
    122. Petru E, Lck HJ, Stuart G, Gaffney D, Millan D, Vergote I (2009). Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol, 143(2), 69-74.
    123. Lee CM, Fuhrman CB, Planelles V, Peltier MR, Gaffney DK, Soisson AP, Dodson MK, Tolley HD, Green CL, Zempolich KA (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12(1), 250-6. ()
    124. Lee CM, Salzman KL, Blumenthal DT, Gaffney DK (2005). Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy. Am J Hematol, 78(2), 151-2. ()
    125. Patton GA, Gaffney DK, Moeller JH (2003). Facilitation of radiotherapeutic error by computerized record and verify systems. Int J Radiat Oncol Biol Phys, 56(1), 50-7. ()

    Review

    1. Gaffney D, Matias-Guiu X, Mutch D, Scambia G, Creutzberg C, Fotopoulou C, Berek JS, Concin N (2024). 2023 FIGO staging system for endometrial cancer: The evolution of the revolution. [Review]. Gynecol Oncol, 184, 245-253. ()
    2. Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W Jr, Erickson B, Gaffney D, Lo SS, Viswanathan AN (2023). Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. [Review]. Pract Radiat Oncol. ()
    3. Ladbury C, Harkenrider M, Taunk N, Fisher C, Mayadev J, Venkat P, Yashar C, Gaffney D, Beriwal S, Glaser S (2023). A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer. [Review]. Brachytherapy. ()
    4. Sagae S, Toita T, Matsuura M, Saito M, Matsuda T, Sato N, Shimizu A, Endo T, Fujii M, Gaffney DK, Small W Jr (2023). Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. [Review]. Int J Gynecol Cancer. ()
    5. Griffith T, Nwachukwu C, Albuquerque K, Gaffney D (2022). The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer. [Review]. Brachytherapy, 21(2), 177-185. ()
    6. Huang YJ, Gaffney D (2022). Brachytherapy: Common pitfalls. [Review]. Int J Gynecol Cancer, 32(3), 352-357. ()
    7. Parsons MW, Huang YJ, Burt L, Suneja G, Gaffney D (2022). Vaginal cuff brachytherapy for endometrial cancer: A review of major clinical trials with a focus on fractionation. [Review]. Int J Gynecol Cancer, 32(3), 311-315. ()
    8. McCormack M, Gaffney D, Tan D, Bennet K, Chavez-Blanco A, Plante M (2021). The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries. [Review]. Int J Gynecol Cancer, 31(5), 775-778. ()
    9. Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, Mayr NA, Moore D, Puthawala AA, Rao GG, Small W Jr, Varia MA, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Gaffney DK (2013). Acr appropriateness Criteria management of vaginal cancer. [Review]. Oncology (Williston Park), 27(11), 1166-73. ()
    10. Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, Jhingran A, Lee LJ, Mayr NA, Puthawala AA, Rao GG, Small W Jr, Wahl AO, Wolfson AH, Yashar CM, Yuh W, Cardenes HR (2013). ACR Appropriateness Criteria(R) management of locoregionally advanced squamous cell carcinoma of the vulva. [Review]. Am J Clin Oncol, 36(4), 415-22. ()

    Book

    1. David K Gaffney, Dennis C Shrieve, Christopher J Anker, Mark K Buyyounouski, Feng-Ming Kong, Ying J Hitchcock, Jonathan D Tward (12/2012). Radiation Oncology: Imaging and Treatment. Amirsys.

    Book Chapter

    1. Boothe D, Gaffney DK (2016). Radiotherapy for Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul: Gunes Publishing.
    2. Orton AW, Gaffney DK (2016). Radiotherapy for Vaginal Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.). (Eds.), Textbook of Gynaecological Oncology (Second). Istanbul:: Gunes Publishing.
    3. Jonathan D Tward, Christopher J Anker, David K Gaffney and Glen M Bowen (March 2012). Radiation Therapy and Skin Cancer. In Modern Practices in Radiation Therapy.
    4. Ghia A, Gaffney DK (2011). Radiotherapy for Vaginal and Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Eds.), Textbook of Gynaecological Oncology (First). Istanbul: Gunes Publishing.
    5. Mayer NA, Gaffney DK, Small Q (May 2011). Cervical Cancer (Ch. 22). In Liu JL, Brady LW (Eds.), Decision Making in Radiation Oncology (pp. 662-701). Springer.
    6. Anker CA, Gaffney DK (2011). Ovary. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 365-384). Philadelphia: Lippencott Williams and Wilkins.
    7. Gonzalez VJ, Gaffney DK (2011). Vagina. In Shrieve DC, Loeffler J (Eds.), Human Radiation Injury (1st, pp. 385-402). Philadelphia: Lippencott WIlliams and Wilkins.

    Conference Proceedings

    1. Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, Konski AA, Gaffney DK, Small W, Thompson JS, Doncals DE, Cantuaria GHC, DSouza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2022). Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared with Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. In Yeung AR|Deshmukh S|Klopp AH|Gil KM|Wenzel L|Westin SN|Konski AA|Gaffney DK|Small W|Thompson JS|Doncals DE|Cantuaria GHC|D'Souza DP|Chang A|Kundapur V|Mohan DS|Haas ML|Kim YB|Ferguson CL|Pugh SL|Kachnic LA|Bruner DW (Ed.), J Clin Oncol, United States, 40(27), 3115-3119. ()
    2. Sagae S, Monk BJ, Pujade-Lauraine E, Gaffney DK, Narayan K, Ryu SY, McCormack M, Plante M, Casado A, Reuss A, Chvez-Blanco A, Kitchener H, Nam BH, Jhingran A, Temkin S, Mileshkin L, Berns E, Scholl S, Doll C, Abu-Rustum NR, Lecuru F, Small W Jr, Gynecologic Cancer InterGroup Cervix Cancer brainstorming day (2016). Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Int J Gynecol Cancer, England, 26(1), 199-207. ()

    Case Report

    1. Bagshaw HP, Williams NL, Huang YJ, Tward JD, Gaffney DK (2015). Palladium interstitial implant in combination with external beam radiotherapy and chemotherapy for the definitive treatment of a female urethral carcinoma. Gynecol Oncol Rep, 13, 40-3. ()

    Editorial

    1. Cruttenden J, Balogun OD, Gaffney D, Suneja G (2024). Destigmatizing gynecologic cancers and prioritizing prospective radiotherapy studies. Gynecol Oncol, 182, 121-123. ()
    2. Dee EC, Eala MAB, Small W Jr, Gaffney DK, Tangco ED, Abdel-Wahab M, Grover S (2022). Equity in Radiation Oncology Trials: from Knowledge Generation to Clinical Translation. Int J Radiat Oncol Biol Phys, 113(3), 511-512. ()
    3. Gaffney D, Creutzberg CL, Jhingran A (2022). Special Issue: Radiation Oncology in Gynecologic Malignancies. Int J Gynecol Cancer, 32(3), 215. ()
    4. Hutten RJ, Huang YJ, Gaffney DK (2021). Stereotactic body radiotherapy for the treatment of gynecologic malignancies: Passing fancy or here to stay? Gynecol Oncol, 161(3), 642-644. ()
    5. Gaffney DK (2012). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? J Gynecol Oncol, 23(4), 207-9. ()

    Letter

    1. Mutch D, Gaffney D, Matias-Guiu X, Fotopoulou C, Concin N, Berek JS, FIGO Endometrial Cancer Subcommittee (2024). Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification. [Letter to the editor]. Int J Gynaecol Obstet. ()
    2. Burt L, Gaffney D (2023). Take Your Best Shot Upfront! [Letter to the editor]. Int J Radiat Oncol Biol Phys, 118(2), 319-320. ()
    3. Concin N, Matias-Guiu X, Fotopoulou C, Creutzberg C, Mutch D, Gaffney D, Lindemann K, Kehoe S, Berek JS, FIGO Committee on Womens Cancer (2023). Response: FIGO staging of endometrial cancer 2023. [Letter to the editor]. Int J Gynaecol Obstet, 164(1), 369-372. ()
    4. Mileshkin LR, Narayan K, Gaffney DK, Barnes EH, Lee YC, Monk BJ, Stockler MR (2023). Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply. [Letter to the editor]. Lancet Oncol, 24(7), e290. ()
    5. Laggis CW, Lamb A, Secrest AM, Ufkes N, Halwani AS, Tao R, Gaffney D, Miles RR, Florell SR, Wada D (2021). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(1), e42-e45. ()
    6. Tward JD, Shrieve DC, Gaffney DK (2006). Author reply [2] [Letter to the editor]. Cancer, 107(11), 2742. ()
    7. Goldwein JW, Podmaniczky KC, Macklis RM, Patton GA, Gaffney DK, Moeller JH (2003). Radiotherapeutic errors and computerized record/verify systems [1] (multiple letters) [Letter to the editor]. Int J Radiat Oncol Biol Phys, 57(5), 1509-1510. ()

    Other

    1. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. Eur J Cancer (202, p. 114017). England. ()
    2. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol (162(2), pp. 454-460). United States. ()